Boston Scientific (BSX)
$31.03 0.03 (0.08%)
13:44 EDT BSX Stock Quote Delayed 20 Minutes
Previous Close $31.05
Market Cap 42.81B
PE Ratio 387.81
Volume (Avg. Vol.) 7.04M
Day's Range 30.63 - 31.52
52-Week Range 24.10 - 46.62
Dividend & Yield N/A (N/A)
BSX Stock Predictions, Articles, and Boston Scientific News
- From InvestorPlace
- From the Web
Growth stocks continue to perform well despite recent market hiccups. These five firms have the potential to keep that growth going for the long haul.
By Thomas Niel
The markets may be taking a dip, but these three healthcare stocks could be your portfolio's prescription as earnings season is in full swing.
Though the market is at all-time highs, not every stock can say the same. These three stocks to buy should reach new peaks in 2020.
Stock charts of BSX, IPG and AES are moving into position for possible swing trades.
The stock charts of BSX, UAL and GM are each at key turning points, though not all necessarily for the better.
Big names like T, MSFT and CRM are on this list that analysts rank as "strong buys." If you're looking to avoid volatility, try these.
Despite all the fear around prescription drug prices, there are some excellent healthcare stocks to buy for interested investors.
The stock charts of HPE, CNC and BSX are going to get the new trading week started on the verge of major moves.
If the market should move from bad to worse in the foreseeable future, these safe stocks to buy should shield you from the worst.
We have been managing a position in Boston Scientific (NYSE:BSX) since early mid-February of this year. BSX is a medical device company that manufactures coronary stent systems, cancer treatment catheter systems, Parkinson’s deep brain stimulation systems and more.
With the Medicare for All Act threatening to impart a radical paradigm shift, healthcare stocks are suddenly under heavy fire.
We are opening a new bullish trade on Boston Scientific (NYSE:BSX). BSX is a medical device company that manufactures coronary stent systems, cancer treatment catheter systems, Parkinson’s deep brain stimulation systems and more.
The stock charts of BSX, MDLZ and FE are at make-or-break points as of Wednesday's close. Here's what you should focus on.
The stock charts of GPS, CNP and BSX are set to get the new trading week started on a narrow path. Here's what to watch.
Not all stocks lost out in 2018. These are the strong-buy stocks that emerged victorious from a year of extremely volatile trading.
I love uncovering the next big thing, but even I recognize the power of blue-chip stocks. These five stocks to buy are at the forefront, making them irresistible.
I am bullish on BSX stock for the long-term. However, I don’t know that right now is the right time to buy Boston Scientific.
Outside the Box: How a fund manager is putting all his ‘stable’ stocks through ‘extreme stress-testing’
From The Motley Fool
From Analyst Ratings
In a report released today, Michael Matson from Needham maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price target of $43.00. The company’s shares closed last Thursday at $30.91. According to TipRanks.com, Matson is a 2-star analyst with an average return of -0.1% and a 49.9% success rate. Matson covers
Coronavirus update: 962,977 global cases, 49,180 deaths and U.S. workers file for benefits in record numbers
The Daily Biotech Pulse: Novartis Scraps Deal To Sell Sandoz Assets, Nevro Pre-Announces Q1 Shortfall, Affimed Granted Orphan Drug Designation
Navellier RatingsPowered by Portfolio Grader